A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
NCT ID: NCT01286194
Last Updated: 2011-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2006-04-30
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental 1
Rabeprazole sodium
Rabeprazole sodium 10 mg orally every day for 14 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rabeprazole sodium
Rabeprazole sodium 10 mg orally every day for 14 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female, 18 years of age or older
* Select and purchase the study medication for their own use
* Be able to take part in periodic telephone interviews regarding their use of and experience with the medication
* Give written informed consent for participation
Exclusion Criteria
* Currently have trouble or pain swallowing food
* Currently have vomiting with blood
* Currently have bloody or black stool
* Currently pregnant or breast-feeding
* Participated in a study regarding a heartburn medication during the last 12 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eisai Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eisai, Inc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Cyrille, MD
Role: STUDY_DIRECTOR
Eisai Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Civic Center Pharmacy
Scottsdale, Arizona, United States
Wynn's Pharmacy, Inc.
Griffin, Georgia, United States
Monfort Drug Company, Inc.
Lawrenceville, Georgia, United States
Eckerd Drug #234
Marietta, Georgia, United States
The Medicine Shoppe
Kansas Ciry, Kansas, United States
Stark Pharmacy
Overland Park, Kansas, United States
Goodrich Pharmacy
Andover, Minnesota, United States
Goodrich Pharmacy
Anoka, Minnesota, United States
Goodrich Pharmacy
Blaine, Minnesota, United States
Goodrich Pharmacy
Elk River, Minnesota, United States
Goodrich Pharmacy
Saint Francis, Minnesota, United States
North Oak Pharmacy
Kansas City, Missouri, United States
Stevenson Family Pharmacy
Saint Joseph, Missouri, United States
Countryside Pharmacy
Savannah, Missouri, United States
Family Prescription Center
Bethlehem, Pennsylvania, United States
T.B. Bond Pharmacy
Hillsboro, Texas, United States
Studewood Pharmacy
Houston, Texas, United States
Kashmere Pharmacy
Houston, Texas, United States
Longhorn Drug Company
Kilgore, Texas, United States
Louis Morgan Drug #1
Longview, Texas, United States
The Medicine Shoppe #1511
Spring, Texas, United States
West Houston Pharmacy
Tyler, Texas, United States
Mountain View Pharmacy
Bountiful, Utah, United States
Gibson United Drug
Murray, Utah, United States
Apothecary Shoppe
Salt Lake Ciry, Utah, United States
Jolley's Corner Pharmacy #1
Salt Lake City, Utah, United States
Family Plaza Pharmacy
West Jordan, Utah, United States
Montpelier Pharmacy, Inc.
Montpelier, Virginia, United States
Lafayette Pharmacy
Richmond, Virginia, United States
Rxtracare/U & I Pharmacy
Bellevue, Washington, United States
Ostrom Drugs
Kenmore, Washington, United States
Manhattan Drug
Seattle, Washington, United States
Kusler's Pharmacy
Snohomish, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E3810-A001-315
Identifier Type: -
Identifier Source: org_study_id